Rebound Insomnia: Causes, Symptoms, and How to Manage It

Key Takeaways:

• Rebound insomnia is a temporary worsening of sleep that can occur after stopping certain sleep medications.

• It has been most widely documented with benzodiazepines and Z-drugs such as zolpidem (Ambien) and eszopiclone (Lunesta), but may also occur with antipsychotics used off-label for sleep and OTC antihistamines.

• Most cases resolve within a few days to about two weeks.

• Gradual tapering under medical supervision is the most effective way to reduce the risk.

Rebound insomnia is a temporary worsening of sleep that can occur after stopping certain insomnia medications. The sleep disruption is often more severe than what you experienced before starting the medication and is not the same as your original insomnia simply returning.

Rebound insomnia is well documented with benzodiazepine sleeping pills and Z-drugs, and some other medications used for sleep may also cause short-term sleep worsening when discontinued.

Although the experience can be frustrating, rebound insomnia is usually temporary and improves as your body adjusts to sleeping without medication.

Rebound Insomnia vs. Regular Insomnia

Rebound insomnia and regular insomnia share similar symptoms but develop for different reasons.

Also Read: Understanding Insomnia: Complete Guide to Better Sleep

What Does Rebound Insomnia Feel Like?

Symptoms typically appear within one to three days of stopping or reducing a sleep medication. They may include:

• Difficulty falling asleep, often taking significantly longer than before treatment

• Waking multiple times during the night

• Waking too early and being unable to fall back asleep

• Increased anxiety or racing thoughts at bedtime

• Sleep that feels shallow or unrefreshing

• Vivid or disturbing dreams, especially after stopping medications that suppress REM sleep, as REM sleep temporarily rebounds

You may also notice daytime effects such as fatigue, irritability, or difficulty concentrating while your sleep patterns stabilize.

Also Read: Nervous System Dysregulation and Sleep

What Causes Rebound Insomnia?

Sleep medications influence neurotransmitters that regulate sleep and wakefulness.

Benzodiazepines and Z-drugs increase GABA activity, which helps calm brain activity linked to alertness. Antihistamines and some antipsychotics block histamine receptors that promote wakefulness. Melatonin supplements add to the body's existing supply.

With regular use, your brain adapts to the presence of these medications. It may produce less of certain chemicals on its own or become less responsive to them. When the medication is stopped, your brain needs time to restore its baseline function. That adjustment period is what produces the rebound.

A study published in The American Journal of Medicine found several factors that influence how severe rebound insomnia can be:

• Drug type. Short- to intermediate-acting benzodiazepines carry the highest documented risk.

• Dose. Rebound is more likely at higher doses. In triazolam studies, rebound occurred at 0.50 mg but not at 0.25 mg, even though both doses had similar sleep benefits.

• Half-life. A drug's half-life is the time it takes for half the medication to leave the body. Short-acting drugs clear quickly and can cause a sharper rebound. Longer-acting drugs clear more gradually, which may ease the transition.

A study of over 1,500 patients with insomnia found that even those taking a placebo experienced a rebound-like worsening of sleep after discontinuation. This suggests that stopping a consistent nightly sleep routine can temporarily affect sleep quality.

Which Medications Are Linked to Rebound Insomnia?

Benzodiazepines

The most extensively studied class for rebound insomnia. These medications affect GABA, a neurotransmitter involved in relaxation. Examples include:

• Triazolam (Halcion)

• Temazepam (Restoril)

• Lorazepam (Ativan)

• Alprazolam (Xanax)

• Diazepam (Valium)

• Clonazepam (Klonopin)

Short-acting benzodiazepines like triazolam leave the body more quickly, which can lead to more noticeable sleep disruption when you stop. Longer-acting drugs like diazepam clear more slowly, so symptoms may be less abrupt but can stretch out over a longer period as levels gradually fall.

Healthcare professionals usually recommend gradually reducing the dose rather than stopping suddenly. Abrupt discontinuation of benzodiazepines can cause severe withdrawal symptoms, including anxiety, nausea, and seizures.

Z-Drugs

Non-benzodiazepine hypnotics that target the same GABA pathways but have different chemical structures. Examples include:

• Zolpidem (Ambien)

• Eszopiclone (Lunesta)

• Zaleplon (Sonata)

These were developed with the intention of having fewer side effects and less potential for dependence than benzodiazepines. A 12-month prospective study found no consistent rebound insomnia with nightly zolpidem at 10 mg in carefully screened patients. However, a 2025 prospective trial published in the journal SLEEP found that eszopiclone (3 mg) produced rebound insomnia on discontinuation, while zolpidem extended-release (12.5 mg) did not. Results vary depending on dose, duration, and individual factors.

Antipsychotics Used Off-Label for Sleep

Approved for conditions such as schizophrenia and bipolar disorder, but commonly prescribed at low doses for insomnia. Examples include:

• Quetiapine (Seroquel)

• Olanzapine (Zyprexa)

• Clozapine (Clozaril)

These medications are sedating partly because they block histamine receptors, the same mechanism behind OTC sleep aids like diphenhydramine. They also affect dopamine and serotonin activity, which contributes to both their sedating effects and the potential for sleep disruption when discontinued.

A systematic review of quetiapine withdrawal found an association between rapid cessation and symptoms including insomnia, agitation, nausea, and anxiety. A separate international survey of 585 antipsychotic users found that 72% reported withdrawal effects when attempting to stop, with insomnia among the most frequently reported symptoms.

OTC Antihistamines

Available without a prescription for occasional sleeplessness. Examples include:

• Diphenhydramine (Benadryl, ZzzQuil)

• Doxylamine (Unisom)

Tolerance may develop with regular use. The American Academy of Sleep Medicine does not recommend these for treating insomnia. Evidence for their effectiveness is limited, and regular use has been linked to next-day drowsiness, cognitive impairment, and, in some research, a higher risk of dementia with long-term antihistamine use.

How Long Does Rebound Insomnia Last?

How long rebound insomnia lasts depends on the type of medication, the dose, how long you were taking it, how quickly you stopped, and the drug's half-life.

These are general ranges; individual experiences vary.

In some situations, rebound insomnia occurs as part of sleep medication withdrawal, especially when medications are stopped abruptly. For many people, sleep improves within several days as the body adjusts.

Does Melatonin Cause Rebound Insomnia?

Melatonin is a hormone naturally produced by the pineal gland in your brain. Production rises in the evening as light decreases, signaling to your body that it is time to sleep.

When you take melatonin supplements regularly, especially at the high doses commonly found in OTC products (5 mg to 10 mg or more), you are giving your body much more melatonin than it normally produces on its own. Clinical studies on doses of 2 to 3 mg taken for up to six to twelve months have not found evidence of rebound insomnia, withdrawal effects, or suppression of natural melatonin production. 

However, your sleep-wake cycle can still come to rely on that nightly signal, and stopping suddenly may cause your sleep to feel lighter or more disrupted for a short time. Research on higher doses taken over longer periods is still limited, and OTC melatonin supplements are unregulated in the U.S., with actual pill content sometimes varying widely from what the label states.

Also Read: Can't Sleep? Discover Why Sip2Sleep® Works Better Than Melatonin

How to Manage Rebound Insomnia

1. Taper Gradually Under Medical Supervision

A slow dose reduction under medical supervision is the most effective way to prevent or minimize rebound insomnia. This is especially important for benzodiazepines, where abrupt discontinuation can cause severe symptoms, including anxiety, nausea, and seizures. Never stop a benzodiazepine without medical guidance.

2. Try CBT-I

Cognitive behavioral therapy for insomnia focuses on the habits and thought patterns that maintain sleep problems. Research supports its effectiveness even when insomnia is triggered by medication changes. Sleep specialists often recommend starting CBT-I before or during the tapering process.

3. Maintain Good Sleep Habits

Basic sleep hygiene practices become especially important during the transition off a sleep medication:

• Keep a consistent wake time every day, including weekends

• Avoid caffeine in the afternoon and evening

• Limit screen time and blue light exposure before bed

• Keep your bedroom cool, dark, and quiet

• Avoid napping during the day, which can reduce sleep pressure at night

These habits will not eliminate rebound insomnia on their own, but they give your body the best possible conditions to re-establish a natural sleep rhythm.

4. Consider a Natural Sleep Aid

If you are tapering off a sleep medication or dealing with rebound insomnia during withdrawal, Sip2Sleep® can complement your existing routine. It is made from Montmorency tart cherry extract, which contains nutrients that support the body's natural melatonin production along with anti-inflammatory properties, and Venetron®, derived from the rafuma plant, which promotes relaxation and helps reduce stress and anxiety. It is non-habit forming with no known side effects. 

When to See a Doctor

Talk to your doctor if:

• Sleep problems persist for more than two to three weeks after stopping a medication

• Severe anxiety, panic attacks, or other withdrawal symptoms develop

• Previous attempts to taper have been unsuccessful

• It is unclear whether the sleep disruption is rebound insomnia or your original sleep disorder returning

Do not adjust the dose of any sleep medication without discussing it with a doctor first.

The Bottom Line

Rebound insomnia is a temporary sleep disturbance that can occur after stopping certain sleep medications. It has been reported with benzodiazepines, Z-drugs, antipsychotics used off-label for sleep, and OTC antihistamines.

Symptoms typically include difficulty falling asleep, nighttime awakenings, and lighter sleep. These changes usually improve as your body adjusts and sleep patterns stabilize.

Gradual medication tapering, CBT-I, consistent sleep habits, and a plant-based sleep aid such as Sip2Sleep® can help during the transition.

Frequently Asked Question

Can rebound insomnia happen after just a few days of taking a sleep medication?

It is possible, but less common. Research on triazolam showed rebound effects after one to two weeks of use at higher doses. A shorter duration at lower doses carries less risk.

Can alcohol worsen rebound insomnia?

Alcohol acts on the same GABA receptors that benzodiazepines and Z-drugs target. While it may help you fall asleep initially, it reduces time in deep sleep and REM sleep and can cause fragmented sleep in the second half of the night. Drinking during rebound insomnia may make symptoms worse and delay recovery.

What is the difference between rebound insomnia and withdrawal?

Rebound insomnia refers specifically to worsened sleep. Withdrawal is a broader set of symptoms that can include anxiety, nausea, dizziness, and irritability, depending on the medication.

Can you prevent rebound insomnia?

The most effective prevention is to taper gradually under medical supervision rather than stopping abruptly. Using the lowest effective dose for the shortest time possible also reduces the risk. However, not all cases can be fully prevented, especially with longer-term use of higher doses.

Why does rebound insomnia feel worse than the original insomnia?

Your brain adapts to the presence of a sleep medication over time. When the medication is stopped, neurotransmitter activity can temporarily shift in the opposite direction, which may make sleep disruption feel more intense than it was before treatment. This effect is temporary.

References

1. Roehrs T, Vogel G, Roth T. Rebound insomnia: its determinants and significance. Am J Med. 1990;88(3A):39S-42S.

2. Koshorek G, Verkler J, Roth T, Roehrs T. Rebound Insomnia During Discontinuation of Chronic Hypnotic Use. Sleep. 2020;43(Supplement_1):A190.

3. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504.

4. Madari S, Golebiowski R, Mansukhani MP, Kolla BP. Pharmacological Management of Insomnia. Neurotherapeutics. 2021;18(1):44-52.

5. Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214-23.

6. Kennedy KM, O'Riordan J. Prescribing benzodiazepines in general practice. Br J Gen Pract. 2019;69(680):152-153.

7. Kales A, Scharf MB, Kales JD, Soldatos CR. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA. 1979;241(16):1692-5.

8. Roehrs TA, Randall S, Harris E, Maan R, Roth T. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol. 2012;26(8):1088-95.

9. Roehrs T, Roth T. BzRA Hypnotic Receptor Specificity and Rebound Insomnia. Sleep. 2025;48(Supplement_1):A238-A239.

10. Carton L, et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals: A systematic review. Curr Pharm Des. 2015;21(23):3280-3297.

11. Miller DD. Atypical antipsychotics: sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 2):3-7.

12. Monahan K, Cuzens-Sutton J, Siskind D, Kisely S. Quetiapine withdrawal: A systematic review. Aust N Z J Psychiatry. 2021;55(8):772-783.

13. Read J. The experiences of 585 people when they tried to withdraw from antipsychotic drugs. Addict Behav Rep. 2022;15:100421.

14. Gray SL, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401-7.

15. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. J Clin Sleep Med. 2017;13(2):307-349.

16. Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Pineal Res. 2007;42(2):171-9.

17. Hajak G, et al. Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur Arch Psychiatry Clin Neurosci. 1998;248(3):148-56.